Dr. Michael
Lawlor
Scientific Advisor
Professor at the Medical College of Wisconsin and the Founder, Owner, and CEO of Diverge Translational Science Laboratory
Dr. Lawlor is a tenured professor of pathology, neurology, biomedical engineering, physiology, cell biology, neurobiology, and anatomy at the Medical College of Wisconsin and the founder, owner, and CEO of Diverge Translational Science Laboratory. He currently directs two clinical laboratories focused on neuromuscular pathology and serves as an editorial board member for the Journal of Neuropathology and Experimental Neurology.
Dr. Lawlor attended Loyola University, where he received his doctoral degree. He trained in anatomic and neuropathology during his residency and fellowship at Massachusetts General Hospital (MGH)/Harvard Medical School. His postdoctoral research training in genetics/genomics was completed at the Children’s Hospital Boston/Harvard Medical School.
Dr. Lawlor’s dedication to understanding and treating neuromuscular and congenital muscular diseases has been awarded multiple research grants and resulted in over 110 publications. He also works with numerous biotech and pharmaceutical companies to support gene therapy programs for muscle, metabolic, and brain disorders.
